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Diagnosis-specific readmission risk prediction
using electronic health data: a retrospective
cohort study
Courtney Hebert1,2*, Chaitanya Shivade3, Randi Foraker4, Jared Wasserman4,7, Caryn Roth1, Hagop Mekhjian5,
Stanley Lemeshow4 and Peter Embi1,6
Abstract
Background: Readmissions after hospital discharge are a common occurrence and are costly for both hospitals and
patients. Previous attempts to create universal risk prediction models for readmission have not met with success. In
this study we leveraged a comprehensive electronic health record to create readmission-risk models that were
institution- and patient- specific in an attempt to improve our ability to predict readmission.
Methods: This is a retrospective cohort study performed at a large midwestern tertiary care medical center. All
patients with a primary discharge diagnosis of congestive heart failure, acute myocardial infarction or pneumonia
over a two-year time period were included in the analysis.
The main outcome was 30-day readmission. Demographic, comorbidity, laboratory, and medication data were
collected on all patients from a comprehensive information warehouse. Using multivariable analysis with stepwise
removal we created three risk disease-specific risk prediction models and a combined model. These models were
then validated on separate cohorts.
Results: 3572 patients were included in the derivation cohort. Overall there was a 16.2% readmission rate. The
acute myocardial infarction and pneumonia readmission-risk models performed well on a random sample validation
cohort (AUC range 0.73 to 0.76) but less well on a historical validation cohort (AUC 0.66 for both). The congestive
heart failure model performed poorly on both validation cohorts (AUC 0.63 and 0.64).
Conclusions: The readmission-risk models for acute myocardial infarction and pneumonia validated well on a
contemporary cohort, but not as well on a historical cohort, suggesting that models such as these need to be
continuously trained and adjusted to respond to local trends. The poor performance of the congestive heart failure
model may suggest that for chronic disease conditions social and behavioral variables are of greater importance
and improved documentation of these variables within the electronic health record should be encouraged.
Keywords: Readmissions, Risk-prediction, Electronic health records
Background
Readmissions are a widespread and costly problem for
hospitals across the United States [1-4]. In 2012, the
average rate of 30-day readmission for Medicare patients
was 24.7% for congestive heart failure (CHF), 18.5% for
pneumonia (PNA) and 19.8% for acute myocardial
infarction (AMI) [5]. There are many incentives for re-
ducing readmission rates from a financial and quality-of-
care perspective [6-9]. However, interventions can be
time- and cost-intensive [10-14] and it may not be cost-
effective to intervene upon every patient regardless of
his or her risk of readmission. Traditionally, healthcare
providers do a poor job of predicting which patients will
be readmitted [15].
Several studies have used administrative and clinical data
to identify predictors of readmission for CHF, PNA and
AMI [16-20], however, few patient-level characteristics are
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consistently associated with risk of readmission [21-26]
and most prediction models perform poorly [27]. Amara-
singham and colleagues developed a prediction model
based on local data, which performed better than models
developed for general use [23]. Even though high readmis-
sion rates are seen in hospitals across the country [4],
data suggest that differences may exist between 30-day re-
admission rates in different settings [2,4,8], indicating that
geographic and socioeconomic factors may affect the likeli-
hood of readmission.
With this in mind, we created prediction models at
our own institution, The Ohio State University Wexner
Medical Center (OSUWMC) that are specific to our pa-
tients, their context, and specific disease state. We devel-
oped prediction models for 30-day readmissions that
examined previously studied, as well as novel variables.
We used variables available in our Information Ware-
house (IW) to build readmission prediction models for
CHF, PNA, AMI and a combined model that included
all three groups. We hypothesized that a model tuned to
a specific disease state would perform better than a
combined model, and that a model created at our own
institution would be uniquely suited for our patient
population and environment. These models are the first
step in a plan to embed a tool into our comprehensive
electronic health record (EHR) to alert physicians to
high-risk patients at the point-of-care.
Methods
Settings and participants
This was a retrospective study using two years of data
collected from the IW at the OSUWMC. The IW cap-
tures all administrative and clinical data during inpatient
hospitalizations. Eligible patients were those admitted to
an inpatient service between August 1, 2009 and July 31,
2011 with a primary discharge diagnosis International
Classification of Diseases, Version 9 Clinical modifica-
tion (ICD-9-CM) code of CHF, PNA, or AMI, as defined
by the Centers for Medicare and Medicaid Services
(CMS) [28].
Definitions
We defined an index hospitalization as the first hospitalization
for CHF, PNA, or AMI during the study period. Our
query excluded index hospitalizations that were followed
by transfer to an acute care setting or resulted in the pa-
tient’s death during the hospitalization. We excluded
index hospitalizations of patients who left against medical
advice (n = 49), as well as admissions that resulted in
same-day discharges for AMI (n = 3). We excluded pa-
tients without 30-days of follow-up after discharge, includ-
ing patients who were discharged within 30 days of the
end of the study and were not readmitted prior to the end
of the study (n = 130) and patients that died within 30 days
of discharge without a readmission (n = 150). Only the
first admission for each patient was included. An overview
of specific inclusion and exclusion criteria can be seen in
Figure 1.
We classified a 30-day readmission as an admission to
an inpatient service between the index hospitalization
discharge date and 30 days after discharge. We consid-
ered admission for any cause to be a readmission, with
the exception of a planned admission for a coronary ar-
tery bypass graft or percutaneous transluminal coronary
angioplasty after an index admission for AMI (n = 4).
We counted only the first readmission for each patient.
We used zip codes as a proxy for patients’ address of
residence. Most patients (74%) lived within 50 miles of
OSUWMC, as indicated by the straight-line distance be-
tween zip code centroids. 69 patients resided more than
125 miles from the OSUWMC. Because we did not have
Figure 1 Inclusion and exclusion criteria for derivation and
random sample validation cohorts.
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data on whether patients were readmitted to other hos-
pitals, we used extreme distance as an indicator that
these patients would likely be readmitted to outside hos-
pitals if they were readmitted, and as such were substan-
tially different from the rest of the cohort. These 69
patients were excluded as outliers.
Data collection
We collected administrative and clinical data on all eli-
gible patients. These data included demographics, comor-
bidities, laboratory results, medication orders, and social
history. We identified comorbidities from administrative
ICD-9-CM codes associated with the index encounter.
We included 31 comorbidities, which we adapted from
ICD-9-CM groupings previously published [29]. We also
calculated a modified Charlson comorbidity score only
using ICD-9-CM associated with the index encounter
[29,30]. All data collected were encounter-level data and
did not include historical or outpatient data.
The number of medications prescribed on discharge
was included as a continuous variable. Medication vari-
ables were collected from the list of discharge medica-
tions. Laboratory values were classified by the highest and
lowest value during the index hospitalization using ac-
cepted clinical cut-points. All included laboratory data
had less than 1% missing data. We did not include most
social history variables (e.g. smoking, employment and liv-
ing situation), as they were not consistently reported in
the EHR. All continuous variables were assessed for ap-
propriate transformations using fractional polynomials.
Because of the small number of patients of races other
than white or black, this variable was defined as black ver-
sus non-black. Age was treated as a continuous variable.
We created a binary variable for marital status, where
“single” included those patients classified as divorced, sin-
gle, widowed, or separated. An inpatient visit in the last
30 days included any admission to an inpatient facility in-
cluding inpatient rehabilitation, but excluding emergency
department (ED) visits that did not result in admission.
A variable representing an ED visit in the last 30 days
represented those ED visits that were not associated with
an inpatient admission.
Validation
We validated our models in two ways. The first method
used a random sample from the original cohort as valid-
ation. We maintained the percentage readmitted in these
validation samples. Ten percent (n = 396) of patients
were randomly removed from the combined model and
20% from the individual models, prior to model creation.
The second method used a historical validation cohort.
We performed a second, identical data pull for patients
admitted between August 1, 2008 and July 31, 2009. We
applied the same exclusion criteria, with one addition: if
patients were already part of the derivation cohort, they
were excluded from the validation cohort (n = 327).
Statistical analysis
We performed all analyses using Stata (StataCorp. 2011.
Stata Statistical Software: Release 12. College Station,
TX: StataCorp LP). We performed univariate analyses
on each variable in the combined derivation cohort and
within CHF, PNA, and AMI subsets and included those
variables in the regression with a p-value <0.2.
We included eligible variables in a stepwise logistic re-
gression against the binary variable, readmission within
30 days. Variables with a p-value <0.1 were allowed
to remain in the model. We estimated odds ratios and
95% confidence intervals for readmission within 30 days.
We evaluated the resulting multivariable models using
the area under the receiver operating characteristic
curves (AUC) and evaluated the goodness-of-fit using
the Hosmer-Lemeshow test. We tested for outliers using
standardized Pearson residuals, Pregibon’s dbeta and
the leverage of each observation [31]. Removing the
outliers resulted in minimal changes in the p-value
for goodness-of-fit and AUC, thus, they remained in
the model.
We applied each of the four derived models to its cor-
responding validation cohort, using the coefficients from
the derivation models. We calculated AUC and evalu-
ated goodness-of-fit. To assess the predictive ability of
each of the models, we calculated the logistic function
(P(y|x) = 1/(1 + (e-b0+b1x))) for each patient in the deriv-
ation cohort, which resulted in a predicted probability of
readmission. We divided these probabilities into tertiles
of risk (low, medium and high). We then calculated
the logistic function for the validation cohort using the
same coefficients. We used the same cutoffs for low-,
medium-, and high-risk determined by the derivation
cohort. We then compared these risks to the actual rate
of readmission in each of the groups for the derivation
and validation cohorts (Figure 1).
The OSUWMC institutional review board (IRB) ap-
proved all data collection. Given that this was a retro-
spective study of data already collected for clinical
purposes, a waiver of informed consent was granted by
the IRB.
Results
Overall findings
The derivation cohort included 3572 patients; 1354 in
CHF, 1171 in PNA and 1047 in AMI. The readmission
rates were 16.2% (n = 577) in the combined cohort,
16.4% (n = 222) in CHF, 18.4% (n = 216) in PNA, and
13.3% (n = 139) in AMI. The clinical characteristics of
patients included in the analysis are described in Table 1.
The mean age was 61 years (IQR 51–72), the majority of
Hebert et al. BMC Medical Informatics and Decision Making 2014, 14:65 Page 3 of 9
http://www.biomedcentral.com/1472-6947/14/65
patients were male, and there was a high prevalence of
comorbidities (data not shown) including diabetes melli-
tus (DM) (39%), chronic pulmonary disease (42%) and
renal disease (28%).
The random-sample validation included 396 (CHF =
148, PNA = 129, AMI = 119) patients in the combined
cohort with a readmission rate of 16.2% (n = 64). The
CHF cohort had 300 patients with a readmission rate of
16.0% (n = 48); the PNA cohort had 258 patients with a
rate of 18.6% (n = 48); and AMI had 230 patients with a
rate of 13% (n = 30).
The historical validation cohort consisted of 1756 pa-
tients (CHF = 610, PNA =552, AMI = 594) with a com-
bined 30-day readmission rate of 17.7% (n = 311). 19.8%
of CHF patients (n = 121), 17.8% of PNA patients (n =
98), and 15.5% of AMI patients (n = 92) were readmitted.
The validation cohort was similar to the derivation co-
hort in all measured patient characteristics (Table 1).
Univariate analysis
Out of over 100 initial variables, there were 43 that met
initial derivation model inclusion criteria (p <0.20) in the
combined model. These variables included demograph-
ics, comorbidities, laboratory values and certain dis-
charge medications.
Multivariable analysis
Derivation cohort
We developed four models using logistic regression with
stepwise removal. None of the models showed evidence
Table 1 Characteristics of the study population
Derivation cohort
N = 3572
Historical validation
cohort
N = 1756
Random sample
combined cohort
N = 396
Readmitted in 30 days 577 (16.2%) 311 (17.7%) 64 (16.2%)
Demographics
Age, median (IQR) 61 (51–72) 62 (52–73) 61 (52–71)
Gender, Female (%) 1541 (43.1%) 759 (43.2%) 162 (40.9%)
Marital status, single* (%) 2023 (56.6%) 988 (56.3%) 203 (51.3%)
Race, Black† (%) 1090 (30.5%) 497 (28.3%) 130 (32.8%)
Distance from the zip code centroid to hospital, miles [median, (IQR)] 9.6 (4.6–46.2) 12 (4.6–53.6) 9.4 (4.6–46.2)
Comorbidities
Charlson Score‡, median (IQR) 3 (1–4) 3 (2–5) 3 (2–4)
Solid tumor 192 (5.4%) 104 (5.9%) 27 (6.8%)
Other neurologic disease 185 (5.2%) 95 (5.4%) 18 (4.6%)
Hypertension 2,533 (70.9%) 1,239 (70.6%) 289 (73.0%)
Lymphoma 86 (2.4%) 46 (2.6%) 8 (2.0%)
Abnormal weight loss 231 (6.5%) 94 (5.4%) 34 (8.6%)
Obesity 550 (15.4%) 258 (14.7%) 67 (16.9%)
Liver disease 154 (4.3%) 61 (3.5%) 18 (4.6%)
Peripheral vascular disease 286 (8.0%) 184 (10.5%) 45 (11.4%)
Arrhythmia 1,149 (32.2%) 722 (41.1%) 145 (36.6%)
Metastatic cancer 106 (3.0%) 74 (4.2%) 15 (3.8%)
Details of hospital visit
Length of stay, median (IQR) 4 (2–7) 4 (3–8) 4 (2–7)
Inpatient visit within the last 30 days 379 (10.6%) 181 (10.3%) 45 (11.4%)
ED visit within the prior 30 days 167 (4.7%) 94 (5.4%) 18 (4.6%)
Number of discharge medications 12 (8–16) 12 (8–16) 12 (8–16)
AMI 1047 (29.3%) 594 (33.8%) 119 (30.1%)
CHF 1354 (37.9%) 610 (34.7%) 148 (37.4%)
PNA 1171 (32.8%) 552 (31.4%) 129 (32.6%)
Abbreviations: IQR interquartile range, ED emergency department, AMI acute myocardial infarction, CHF congestive heart failure, PNA pneumonia.
*Single includes single, widowed, divorced and separated.
†Versus not black.
‡Calculated only using ICD-9 data from the index encounter.
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of a lack-of-fit. The AUC for the derivation models
ranged from 0.64 to 0.73 (Additional file 1). All models
included the variable prior admission in the last 30 days
as a risk factor for readmission, while three of the four
models included number of discharge medications and a
diagnosis of lymphoma (Figure 2). All other variables
were included in only one or two models.
Validation cohort
When the models developed in the derivation cohort
were tested on the random sample validation cohort, the
AUCs ranged from 0.63 to 0.76 (Additional file 1) and
showed no evidence of a lack-of-fit. The model was able
to appropriately group patients into high-, medium-, and
low-risk groups (Figure 3). When the historical cohort
was used for validation, the AUCs were lower, ranging
from 0.61 to 0.68. The combined model and AMI model
showed no evidence of a lack-of-fit on the historical val-
idation cohort, however, the PNA and CHF models
failed to satisfy the goodness-of-fit test. Receiver operat-
ing characteristic curves for each of the validation co-
horts are available in Additional file 2.
Discussion
In this study we collected two years of retrospective data
in order to determine risk factors for 30-day readmis-
sion. We created four prediction models using logistic
regression. Our models have moderately good predictive
ability in a random sample validation, and less so in a
historical cohort. Previous admission in the last 30 days
was included in all models, while other variables were
unique to one or two of the models.
This study adds to the current literature in several
ways. First, the models were validated on a contempor-
ary random sample cohort as well as a historical cohort.
We found that the models performed much better on
the contemporary cohort. This may be due to quality
improvement initiatives implemented after the time the
historical data were collected. These resulted in lower
readmission rates and potentially different risk factors
for readmission in the derivation cohort, making the
models less generalizable. This highlights the need for
models to be updated and trained on current data in
order to account for secular trends.
Second, the disease-specific models generally per-
formed better than the combined, suggesting that a
disease-specific approach to prediction is superior. This
is likely due to the differing characteristics of these con-
ditions, resulting in inconsistent effects of the variables
we studied. When these heterogeneous conditions are
combined, the resulting model has lower predictive abil-
ity for readmission. The exception to this finding was
the CHF model, which was the poorest performing
model. This may be because CHF is unique in that it is a
chronic disease. In the AMI and PNA cohorts there are
otherwise healthy patients mixed in with the chronically
ill, and our models are able to discriminate between
these two groups. The CHF group includes patients who
are chronically ill by definition, and so their risk factors
for readmission are more difficult to identify using a tool
that mainly accounts for comorbidities and hospital and
medication utilization. Future plans to improve the CHF
model include adding non-clinical risk factors such as
neighborhood socioeconomic status and more enriched
social history data to the model.
Finally, our models focused on only encounter level var-
iables, not including ICD-9-CM that had been previously
recorded or lab values from previous admissions. This was
done for two reasons. One was to avoid biasing the model
toward patients who receive all their care at OSUWMC
and would therefore have more recorded historical data.
The other was so that these models could be turned into a
tool that resides in the EHR, in order to predict readmis-
sions at the point-of-care. Several barriers need to be over-
come in order to integrate the predictive model into the
EHR, including mapping our variables to appropriate
fields in the new EHR platform, identifying the targeted
cohort for the alert, deciding who should get the alert and
when the alert would be triggered. In light of our findings
in this study, we also acknowledge it is critical for these
models to be dynamic, prospectively trained, and able to
adjust to changes in patient population, improved dis-
charge procedures, and temporal trends in treatment.
It was not the goal of this study to identify specific risk
factors for readmission, but rather to develop a model
that predicted readmission. Nevertheless, it is valuable
to examine the variables that we found to be markers of
readmission in light of previous research.
Hospital utilization was important in all of the models.
Length of stay and ED visit or inpatient visit in the last
30 days were common to several of the models. This
trend has been seen in many other studies [7,32], likely
reflecting the fact that a large percentage of the hospital
resources in our country are utilized by a small percent-
age of patients [10]. In previous studies, demographic
factors such as marital status, age and gender have been
shown to be predictive of 30-day readmission [21,33,34].
Single marital status was a predictor in the combined
model, which may suggest a lack of power to detect a
significant finding in the smaller cohorts. Gender was
not a risk factor in any model nor was age.
Comorbidities have been important predictors of re-
admission in other studies, specifically diabetes and renal
failure [35-37]. The comorbidities that we found to be
predictive were diverse and included other neurologic
disease, cancer, and abnormal weight loss. Surprisingly,
renal failure, diabetes or other chronic medical issues
were not predictive of readmission in this cohort. This
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may be because earlier initiatives had focused on these
high-risk patients, and may have decreased the readmis-
sion rate for this group.
Several studies have pointed to the increased risk of
readmission due to certain medications. In a recent
study by Budnitz et al., adverse drug reactions due to
warfarin, insulin, oral hypoglycemic and antiplatelet
agents accounted for a significant proportion of hospital-
izations [38]. We did not find an association with these
medications; however, the number of medications pre-
scribed on discharge was included in three of our
models, likely reflecting the risk of polypharmacy [39].
There are several limitations to our study. The EHR
platform that was present when the derivation cohort
was drawn did not adequately collect social history data
such as smoking status (67% missing) and living situ-
ation (55% missing). We are working to ensure that our
new EHR platform has more complete data on these risk
factors. We were also limited to our own medical sys-
tem’s data. Same-hospital readmission is thought to
occur in only 80% of cases [40]. This means we could
have misclassified patients if they were readmitted else-
where. Similarly, if a patient was initially admitted at an-
other hospital, we could have erroneously classified their
readmission as an index admission at our institution or
misclassified them for the variable admission in the pre-
vious 30 days. A risk period of 30 days is an arbitrary
cutoff and motivated by CMS guidelines. It may be more
meaningful to know which patients are going to return
to the hospital in the first few days after discharge. We
are working to develop cox-proportional hazard models
as a next step. Although these data are from one hospital
system, and the same predictors may not be risk factors
at other large referral centers, the methodology we used
to develop the models can be used in other settings.
This was a retrospective study with a goal to create a
prediction model. The variables that we found to be sig-
nificant are likely markers for high-risk patients, but are
not necessarily risk factors in themselves and thus
should not be highlighted as targets for intervention. A
reasonable use for this type of model would be to flag
high risk patients within the EHR for prespecified re-
admission reduction interventions which would not be
Figure 2 Variables included in final regression models for each
comorbid condition. *Based on the enhanced ICD-9 coding of the
Elixhauser comorbidity classification [29]. Hypertension combines
hypertension, uncomplicated with complicated. Only used data from
index encounter. †Versus not black. ‡At least once during the index
hospitalization. §Excluding topical steroids. || Documented in the
social history. **Single includes single, widowed, divorced and
separated. ††Using ICD-9 procedure codes during index
hospitalization.
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feasible to roll out to all hospitalized patients, either due
to cost or person-time. As a next step, we will attempt
to address the aforementioned limitations. Results from
this study will inform changes in the EHR system, and
improvements in data collection methods are currently
underway. Once our models are integrated in the EHR,
we will prospectively train the model to continuously re-
fine and improve its predictive accuracy. We plan to en-
rich these data with information from other sources,
including outpatient pharmacy data, clinic visits that
occur outside of the OSUWMC, and payer data. We are
also exploring further statistical analysis and artificial
intelligence approaches to complement our logistic re-
gression methodology.
Conclusion
Using two years of retrospective administrative and clin-
ical data from our EHR, we developed models to identify
patients at risk for 30-day hospital readmission. Our
study suggests that disease-specific readmission predic-
tion models are better able to distinguish high-risk pa-
tients from low-risk patients. We can use these models
in our hospital system to identify inpatients that are at
high risk, and target interventions to prevent readmis-
sions. As we continue to train our models prospectively
and augment our analysis with additional data sources
and methods, we believe we will develop even more ac-
curate prediction models.
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